Nachrichten zur Eli Lilly & Co. Aktie

Eli Lilly Now Has the Worlds Best-Selling Drug -- But Does That Make the Stock a No-Brainer Buy?

Mounjaro generated $8.66 billion in sales in the first quarter.…

What the FDAs Latest Proposal Means for Lilly, Novo, and Hims

The FDAs latest proposal would be a win for Eli Lilly and Novo Nordisk, while Hims & Hers Health would…

Novo and Lilly gain on signs weight-loss pills could expand the market

Early data from weight-loss pills are lifting shares in Novo Nordisk and Eli Lilly as investors bet that easier-to-take drugs…

Eli Lilly stock swings after FDA liver failure report for GLP-1 drug

Eli Lilly (LLY) stock initially sold off on Monday morning, May 4, after the FDA disclosed a liver failure report…

Lilly commits additional $4.5 billion across Indiana manufacturing sites

Eli Lilly said on ?Wednesday it would commit an additional $4.5 billion ?investment across two of its three sites in…

Top Research Reports for Eli Lilly, Western Digital & Vertiv

Eli Lillys strong GLP-1 drug demand and pipeline advances drive growth, while Western Digital and Vertiv ride AI-fueled momentum and…

3 Reasons Its Not Too Late to Buy Eli Lilly Stock

The company still has a strong lead in its core therapeutic area.…

Novo Nordisk’s head start on GLP-1 pills forces investors to rethink Eli Lillys dominance

Early signs from the launch of Novo Nordisks Wegovy pill and Eli Lilly & Co.s Foundayo are making investors rethink…

Whats behind Eli Lillys down-and-up day after last weeks post-earnings surge

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Why Eli Lilly stock is down 3% today: FDA adverse event data explained

Why Eli Lilly stock is down 3% today: FDA adverse event data explained…

Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering

PHILADELPHIA, May 04, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage…

Eli Lilly Just Announced Fantastic News for Shareholders

Lillys weight loss drugs have been delivering blockbuster revenue.…

Novo Nordisk Before Q1 Earnings: How Should Investors Play the Stock?

NVO heads into Q1 with strong GLP-1 drug demand and new Wegovy pill rollout, but pricing pressure, weak guidance and…

Eli Lilly and Company 2026 Q1 - Results - Earnings Call Presentation

…

BofA sees more upside in Eli Lilly stock

Eli Lilly’s first-quarter report gave Wall Street another reason to stay optimistic about one of the market’s biggest pharmaceutical winners,…

Eli Lilly: Buying Opportunity Knocking On The Front Door Again (Rating Upgrade)

…

ResMed (RMD) Q3 2026 Earnings Transcript

Image source: The Motley Fool.DateApr. 30, 2026, 4:30 p.m. ETCall participantsChief Executive Officer — Michael J. FarrellChief Financial Officer —…

Eli Lilly shares surge on a beat-and-raise, proving the stocks swoon was a mistake

Eli Lilly entered Thursday well off its highs. A blowout quarter shows the market got this one wrong.…

Stocks making the biggest moves midday: Blue Owl, Qualcomm, Hertz, Eli Lilly, Meta Platforms, Microsoft & more

Here are the stocks making headlines in midday trading.…

ROUNDUP 2: Überraschend starkes Quartal für Lilly - Ziele angehoben

(Kurs aktualisiert) INDIANAPOLIS (dpa-AFX) - Der US-Pharmakonzern Lilly hat dank der ungebrochen…

Eli Lilly (LLY) – Der Pharmariese entfacht mit Abnehm-Medikamenten neuen Wachstumsrausch und hebt Jahresprognose deutlich an!

Eli Lilly liefert ein Quartal zum Staunen: Umsatz +56 % auf 19,8 Mrd. USD, EPS bei 8,55 USD weit über…

Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.…

Market movers: Qualcomm, Hertz, Eli Lilly, Royal Caribbean, 374Water…

…

ROUNDUP: Überraschend starkes Quartal für Lilly - Pharmahersteller erhöht Ziele

INDIANAPOLIS (dpa-AFX) - Der US-Pharmakonzern Lilly hat dank der ungebrochen hohen Nachfrage nach seinen Gewichtssenkern…

Gewichtssenker-Hersteller Lilly erhöht nach überraschend gutem Quartal Prognose

INDIANAPOLIS (dpa-AFX) - Der US-Pharmakonzern Lilly hat dank der ungebrochen hohen Nachfrage nach seinen Gewichtssenkern…

More than 20,000 people are taking Eli Lillys weight loss pill Foundayo, CEO says

Eli Lillys weight loss pill launch has been closely watched after the successful start of Novo Nordisks Wegovy pill.…

Stocks making the biggest moves premarket: Meta, Eli Lilly, Caterpillar, Amazon & more

These are the stocks posting the largest moves in the premarket.…

Eli Lilly crushes Q1 estimates, raises full-year outlook as GLP-1 sales surge

Eli Lilly and Co (NYSE:LLY) reported stronger-than-expected first-quarter 2026 results on April 30, driven by surging demand for its diabetes…

Eli Lilly raises annual profit forecast as GLP-1 drugs fuel growth

Eli Lilly raised its annual profit forecast and posted better-than-expected first quarter on Thursday, on steady demand for its ?weight-loss…

Eli Lilly raises annual profit forecast on sustained weight-loss drug demand

Eli Lilly raises annual profit forecast on sustained weight-loss drug demand…

Hims & Hers: The Telehealth Stock Caught Between a Lilly Lifeline and an Amazon Ambush

Hims & Hers navigates a pivotal moment: a new Eli Lilly distribution deal lifts analyst targets, whi…

Mehrere Milliarden-Deals und Medizin-Revolution! Eli Lilly zündet mit Foundayo die nächste Wachstumsstufe!

Der US-Pharmagigant Eli Lilly (LLY) schlägt erneut kräftig auf dem Übernahmemarkt zu und untermauert gleichzeitig mit herausragenden Studiendaten seine Vormachtstellung.…

FDA Update Puts Hims And Hers Weight Loss Partnerships In Focus

Regulators are scheduled to meet in July to discuss FDA guidance that could influence how NYSE:HIMS expands its weight-loss and…

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Novartis, Amgen and Eli Lilly are betting that slashing levels of a particularly bad form of cholesterol could deliver the…

Biggest winner of the amended Microsoft-OpenAI deal — plus, mixed news for Eli Lilly

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Eli Lilly to buy Ajax Therapeutics for up to $2.3 billion in blood cancer bet

Eli Lilly said on Monday it would buy privately held blood cancer treatment developer Ajax Therapeutics for up to $2.3…

Should You Add a Healthcare Stock to Your Portfolio This Month? And Should It Be Eli Lilly (LLY)?

Eli Lilly is a giant in the weight-loss drug realm, and its aiming to grow more.…

A Look At Hims & Hers Health (HIMS) Valuation After Fresh GLP-1 Analyst Endorsement And Pharma Partnerships

Hims & Hers Health (HIMS) is back in focus after fresh analyst coverage spotlighted its Novo Nordisk partnership and broader…

Why Eli Lilly (LLY) Shares Are Trading Lower Today

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.6% in the afternoon session after disappointing weekly prescription numbers for…

Eli Lilly: A Heavyweight Battle Isnt Won In Round 1

…

Stocks making the biggest moves midday: Intel, AMD, Charter, Hims & Hers, Eli Lilly and more

These are the stocks posting the largest moves in midday trading.…

Stocks making the biggest moves midday: Intel, AMD, Charter, Hims & Hers, Eli Lilly and more

These are the stocks posting the largest moves in midday trading.…

How Expanding GLP?1 Offerings and Partnering With LillyDirect At Hims & Hers Health (HIMS) Has Changed Its Investment Story

In recent days, Hims & Hers Health expanded its platform so clinicians can prescribe Eli Lilly GLP?1 weight loss treatments,…

dpa-AFX ProFeed